乙肝共信号受体调节的治疗潜力
Francesco Andreata1, Chiara Laura2, Micol Ravà1
1Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Cell
|June 19, 2024
概括
在慢性乙型肝炎 (HBV) 感染中逆转CD8+ T细胞功能障碍是关键. 激活4-1BB和OX40共信号受体可以恢复抗病毒功能,提供有前途的治疗策略.
科学领域:
- 免疫学
- 肝病学
- 病毒学
背景情况:
- CD8+ T 细胞功能障碍会影响慢性乙型肝炎病毒感染的控制.
- 扭转这种功能障碍的具体分子目标仍然难以捉摸.
研究的目的:
- 分析HBV特异性CD8+T细胞上的共信号受体表达.
- 研究共信号受体调制恢复抗病毒功能的潜力.
主要方法:
- 对HBV特异性CD8+T细胞的共信号受体表达 (PD-1,CTLA-4,LAG-3,OX40,4-1BB,ICOS) 的分析.
- 在体外刺激测定包括阻断共抑制受体和激活共刺激受体 (4-1BB,OX40).
- 使用转录造型对T细胞群体 (T_SL,T_RM) 的表征.
主要成果:
- 功能障碍的CD8+T细胞可以调节多个共信号受体.
- 4-1BB和OX40的激活,但不阻断共抑制受体,恢复了抗病毒效应的功能.
- 长期刺激产生了异质的T细胞群,包括干状 (T_SL) 和组织内存 (T_RM) 细胞.
- 在慢性情况下和HBeAg+患者中,4- 1BB刺激是有效的,显示T细胞再生的潜力.
结论:
- 针对共同信号通路,特别是4 - 1BB激活,可以逆转慢性HBV的CD8+T细胞功能障碍.
- 恢复干细胞样和效应记忆T细胞群的抗病毒活性对于有效治疗至关重要.
- 调节4-1BB为慢性乙型肝炎患者提供了一个有前途的治疗途径.
更多相关视频
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


